TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,049 Cr | ₹905 Cr | ₹186 Cr | ₹-134 Cr | ₹750 Cr |
What is the latest Net Current Assets ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,049 Cr |
| Mar2025 | ₹905 Cr |
| Mar2024 | ₹186 Cr |
| Mar2023 | ₹-134 Cr |
| Mar2022 | ₹750 Cr |
How is Net Current Assets of TORRENT PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,049 Cr | 15.81 | |
| Mar2025 | ₹905 Cr | 386.16 | |
| Mar2024 | ₹186 Cr | Positive | |
| Mar2023 | ₹-134 Cr | Negative | |
| Mar2022 | ₹750 Cr | - | |
Compare Net Current Assets of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹149,528.8 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,654.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
| MANKIND PHARMA | ₹96,492.8 Cr | 0.7% | -1.1% | -4.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.6% |
1.4% |
36.7% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses